Search research articles
Contact Us
Filters
Showing results (171-180 of 276) with videos related to
Page
of 28
Sort By:
Acta Dermato-Venereologica
|
February 15, 2020
Patient Preferences in Adjuvant and Palliative Treatment of Advanced Melanoma: A Discrete Choice Experiment
Juliane Weilandt, Katharina Diehl, Marthe Lisa Schaarschmidt, et al.
Oncoimmunology
|
September 22, 2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
Jessica C Hassel, Huanhuan Jiang, Carolin Bender, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2024
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling
Feyza Gül Özbay Kurt, Beatrice-Ana Cicortas, Bianca M Balzasch, et al.
Journal for Immunotherapy of Cancer
|
September 16, 2022
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
Ihor Arkhypov, Feyza Gül Özbay Kurt, Rebekka Bitsch, et al.
Experimental Hematology & Oncology
|
March 11, 2023
Secretogranin II influences the assembly and function of MHC class I in melanoma
Tamara Steinfass, Juliane Poelchen, Qian Sun, et al.
Stem Cell Research & Therapy
|
October 18, 2017
Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells
Patrick A Schweizer, Fabrice F Darche, Nina D Ullrich, et al.
International Journal of Cancer
|
June 12, 2025
Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells
Juliane Poelchen, Sandra Pardo, Daniel Novak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up
Selma Ugurel, Thomas Mentzel, Jochen Utikal, et al.
Oncotarget
|
April 6, 2017
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
Ioana Cosgarea, Selma Ugurel, Antje Sucker, et al.
International Journal of Cancer
|
April 27, 2026
The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition
Tim Zell, Julian Kött, Noah Zimmermann, et al.
Page
of 28
Search research articles
Search
Showing results (171-180 of 276) with videos related to
Sort By:
Page
of 28
Acta Dermato-Venereologica
|
February 15, 2020
Patient Preferences in Adjuvant and Palliative Treatment of Advanced Melanoma: A Discrete Choice Experiment
Juliane Weilandt, Katharina Diehl, Marthe Lisa Schaarschmidt, et al.
Oncoimmunology
|
September 22, 2017
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
Jessica C Hassel, Huanhuan Jiang, Carolin Bender, et al.
Journal for Immunotherapy of Cancer
|
September 12, 2024
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling
Feyza Gül Özbay Kurt, Beatrice-Ana Cicortas, Bianca M Balzasch, et al.
Journal for Immunotherapy of Cancer
|
September 16, 2022
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
Ihor Arkhypov, Feyza Gül Özbay Kurt, Rebekka Bitsch, et al.
Experimental Hematology & Oncology
|
March 11, 2023
Secretogranin II influences the assembly and function of MHC class I in melanoma
Tamara Steinfass, Juliane Poelchen, Qian Sun, et al.
Stem Cell Research & Therapy
|
October 18, 2017
Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells
Patrick A Schweizer, Fabrice F Darche, Nina D Ullrich, et al.
International Journal of Cancer
|
June 12, 2025
Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells
Juliane Poelchen, Sandra Pardo, Daniel Novak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up
Selma Ugurel, Thomas Mentzel, Jochen Utikal, et al.
Oncotarget
|
April 6, 2017
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations
Ioana Cosgarea, Selma Ugurel, Antje Sucker, et al.
International Journal of Cancer
|
April 27, 2026
The Cancer Immunotherapy Thromboembolism Assessment: A Novel Score for Predicting Thromboembolic Events in Melanoma Patients Treated With Immune Checkpoint Inhibition
Tim Zell, Julian Kött, Noah Zimmermann, et al.
Page
of 28